PTC Therapeutics to Host Conference Call to Discuss First Quarter 2025 Financial Results
PTC Therapeutics (NASDAQ: PTCT) has announced a webcast conference call scheduled for Tuesday, May 6, at 4:30 p.m. ET. The call will present the company's first quarter 2025 financial results along with updates on business operations and future outlook.
Participants are advised to register in advance for dial-in details and join 15 minutes before the start time to avoid delays. The webcast will be accessible through PTC's investor relations website, with a replay available for 30 days after the call.
PTC Therapeutics (NASDAQ: PTCT) ha annunciato una conferenza telefonica in webcast programmata per martedì 6 maggio alle 16:30 ET. Durante la chiamata verranno presentati i risultati finanziari del primo trimestre 2025 dell'azienda, insieme ad aggiornamenti sulle operazioni commerciali e sulle prospettive future.
Si consiglia ai partecipanti di registrarsi in anticipo per ricevere i dettagli di accesso e di collegarsi 15 minuti prima dell'inizio per evitare ritardi. Il webcast sarà accessibile tramite il sito web delle relazioni con gli investitori di PTC, con una replica disponibile per 30 giorni dopo la chiamata.
PTC Therapeutics (NASDAQ: PTCT) ha anunciado una conferencia telefónica en webcast programada para el martes 6 de mayo a las 4:30 p.m. ET. En la llamada se presentarán los resultados financieros del primer trimestre de 2025 de la compañía, junto con actualizaciones sobre las operaciones comerciales y las perspectivas futuras.
Se recomienda a los participantes registrarse con anticipación para obtener los detalles de acceso y unirse 15 minutos antes del inicio para evitar retrasos. El webcast estará disponible a través del sitio web de relaciones con inversores de PTC, con una repetición accesible durante 30 días después de la llamada.
PTC Therapeutics (NASDAQ: PTCT)는 5월 6일 화요일 오후 4시 30분(동부시간)에 예정된 웹캐스트 컨퍼런스 콜을 발표했습니다. 이번 콜에서는 회사의 2025년 1분기 재무 실적과 사업 운영 현황 및 향후 전망에 대한 업데이트가 제공됩니다.
참석자들은 접속 정보를 받기 위해 사전 등록을 권장하며, 지연을 방지하기 위해 시작 15분 전에 접속할 것을 권고합니다. 웹캐스트는 PTC 투자자 관계 웹사이트를 통해 접속할 수 있으며, 콜 종료 후 30일간 다시보기 서비스를 제공합니다.
PTC Therapeutics (NASDAQ : PTCT) a annoncé une conférence téléphonique en webcast prévue pour le mardi 6 mai à 16h30 ET. Lors de cet appel, les résultats financiers du premier trimestre 2025 de l'entreprise seront présentés, ainsi que des mises à jour sur les opérations commerciales et les perspectives futures.
Il est conseillé aux participants de s'inscrire à l'avance pour obtenir les détails d'accès et de se connecter 15 minutes avant le début afin d'éviter tout retard. Le webcast sera accessible via le site des relations investisseurs de PTC, avec un replay disponible pendant 30 jours après l'appel.
PTC Therapeutics (NASDAQ: PTCT) hat eine Webcast-Konferenzschaltung für Dienstag, den 6. Mai, um 16:30 Uhr ET angekündigt. Während des Anrufs werden die Finanzergebnisse des ersten Quartals 2025 des Unternehmens sowie Updates zu Geschäftsaktivitäten und zukünftigen Aussichten präsentiert.
Teilnehmer werden gebeten, sich im Voraus zu registrieren, um Einwahldaten zu erhalten, und sich 15 Minuten vor Beginn einzuwählen, um Verzögerungen zu vermeiden. Der Webcast ist über die Investor-Relations-Website von PTC zugänglich, mit einer Wiedergabe, die 30 Tage nach dem Anruf verfügbar ist.
- None.
- None.
To access the call by phone, please click here to register and you will be provided with dial-in details. To avoid delays, we recommend participants dial in for the conference call 15 minutes prior to the start of the call. The webcast conference call can be accessed on the Investors section of the PTC website at https://ir.ptcbio.com/events-presentations. A replay of the call will be available approximately two hours after completion of the call and will be archived on the company's website for 30 days.
ABOUT PTC THERAPEUTICS, INC.
PTC is a global biopharmaceutical company focused on the discovery, development and commercialization of clinically differentiated medicines that provide benefits to children and adults living with rare disorders. PTC's ability to globally commercialize products is the foundation that drives investment in a robust and diversified pipeline of transformative medicines and our mission to provide access to best-in-class treatments for patients who have an unmet medical need. The company's strategy is to leverage its strong scientific expertise and global commercial infrastructure to maximize value for its patients and other stakeholders. To learn more about PTC, please visit us at www.ptcbio.com and follow us on Facebook, X, and LinkedIn.
For more information please contact:
Investors:
Ellen Cavaleri
+1 (615) 618-8228
ecavaleri@ptcbio.com
Media:
Jeanine Clemente
+1 (908) 912-9406
jclemente@ptcbio.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/ptc-therapeutics-to-host-conference-call-to-discuss-first-quarter-2025-financial-results-302428596.html
SOURCE PTC Therapeutics, Inc.
FAQ
When will PTC Therapeutics (PTCT) report Q1 2025 earnings?
How can investors access PTC Therapeutics' Q1 2025 earnings call?
How long will PTC Therapeutics' Q1 2025 earnings call replay be available?
What topics will be covered in PTC Therapeutics' Q1 2025 earnings call?
